Tylenol Extra Strength
- Product NDC
- 50580-937
- 11-digit product format
- 505800937
- Labeler code
- 50580
- Product ID
- 50580-937_572fcd5f-40f6-eaf1-e063-6294a90a4143
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Kenvue Brands LLC
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2019-08-19
- Substance
- ACETAMINOPHEN
- Active strength
- 500 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 50580-937 | 50580-937-03 | D | Discontinued by firm | 2026-10-15 | |
| excluded package | package | 50580-937 | 50580-937-04 | D | Discontinued by firm | 2026-10-15 | |
| excluded package | package | 50580-937 | 50580-937-05 | D | Discontinued by firm | 2026-10-15 | |
| excluded package | package | 50580-937 | 50580-937-20 | D | Discontinued by firm | 2026-10-15 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 50580-937-04 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 50580-937-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 50580-937-03 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 50580-937-20 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 50580-937-04 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 50580-937-05 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 50580-937-03 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 50580-937-20 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 50580-937-04 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 50580-937-05 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 50580-937-03 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 50580-937-20 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 50580-937-04 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 50580-937-05 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 50580-937-03 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 50580-937-20 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 50580-937-04 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 50580-937-05 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 50580-937-03 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 50580-937-20 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 50580-937-04 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 50580-937-05 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 50580-937-03 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 50580-937-20 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 50580-937-04 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 50580-937-20 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 50580-937-05 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 50580-937-03 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 50580-937-04 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 50580-937-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 50580-937-05 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 50580-937-03 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 50580-937-04 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 50580-937-20 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 50580-937-05 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 50580-937-03 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 50580-937-04 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 50580-937-20 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 50580-937-05 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 50580-937-03 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 50580-937-20 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 50580-937-04 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 50580-937-05 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 50580-937-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 50580-937-20 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 50580-937-04 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 50580-937-05 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 50580-937-03 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tylenol Extra Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 103d109d-f520-409c-8da2-eb6b0fbec891 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50580-937-01 | Tylenol Extra Strength | 10 in 1 VIAL | TABLET, FILM COATED | 10 | 15 | |
| 50580-937-01 | Tylenol Extra Strength | 12 in 1 PACKAGE | TABLET, FILM COATED | 12 | 15 | |
| 50580-937-02 | Tylenol Extra Strength | 10 in 1 VIAL | TABLET, FILM COATED | 10 | 15 | |
| 50580-937-02 | Tylenol Extra Strength | 12 in 1 PACKAGE | TABLET, FILM COATED | 12 | 15 | |
| 50580-937-03 | Tylenol Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 15 | |
| 50580-937-04 | Tylenol Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 15 | |
| 50580-937-04 | Tylenol Extra Strength | 3 in 1 CARTON | TABLET, FILM COATED | 3 | 15 | |
| 50580-937-05 | Tylenol Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 15 | |
| 50580-937-05 | Tylenol Extra Strength | 50 in 1 CARTON | TABLET, FILM COATED | 50 | 15 | |
| 50580-937-06 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 15 | |
| 50580-937-06 | Tylenol Extra Strength | 24 in 1 BOTTLE | TABLET, FILM COATED | 24 | 15 | |
| 50580-937-07 | Tylenol Extra Strength | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 15 | |
| 50580-937-07 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 15 | |
| 50580-937-10 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 15 | |
| 50580-937-10 | Tylenol Extra Strength | 50 in 1 BOTTLE | TABLET, FILM COATED | 50 | 15 | |
| 50580-937-15 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 15 | |
| 50580-937-15 | Tylenol Extra Strength | 225 in 1 BOTTLE | TABLET, FILM COATED | 225 | 15 | |
| 50580-937-19 | Tylenol Extra Strength | 325 in 1 BOTTLE | TABLET, FILM COATED | 325 | 15 | |
| 50580-937-20 | Tylenol Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 15 | |
| 50580-937-20 | Tylenol Extra Strength | 50 in 1 CARTON | TABLET, FILM COATED | 50 | 15 | |
| 50580-937-23 | Tylenol Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 15 | |
| 50580-937-23 | Tylenol Extra Strength | 3 in 1 CARTON | TABLET, FILM COATED | 3 | 15 | |
| 50580-937-25 | Tylenol Extra Strength | 2500 in 1 CASE | TABLET, FILM COATED | 2500 | 15 | |
| 50580-937-25 | Tylenol Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 15 | |
| 50580-937-37 | Tylenol Extra Strength | 320 in 1 BOTTLE | TABLET, FILM COATED | 320 | 15 | |
| 50580-937-50 | Tylenol Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 15 | |
| 50580-937-50 | Tylenol Extra Strength | 50 in 1 CARTON | TABLET, FILM COATED | 50 | 15 | |
| 50580-937-51 | Tylenol Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 15 | |
| 50580-937-51 | Tylenol Extra Strength | 50 in 1 CARTON | TABLET, FILM COATED | 50 | 15 | |
| 50580-937-66 | Tylenol Extra Strength | 2 in 1 CARTON | TABLET, FILM COATED | 2 | 15 | |
| 50580-937-66 | Tylenol Extra Strength | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 15 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50580-937-37 | EA - Each | 50580-937 | ee4ac13a-9d32-4472-8a8d-c00203238d98 | 1 | 2026-04-20 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aspirin 81 mg Low Dose | ASPIRIN | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 23b29044-6389-42ea-839a-5351557a6ce3 | 2026-04-23 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 4a70867e-481d-4f01-9da3-d85663a1672e | 2026-04-23 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | United Natural Foods, Inc. dba UNFI | 07edcb31-d31d-4607-98c3-dcb1e062cc70 | 2026-04-22 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Cardinal Health 107, LLC | ee50c5ee-1a61-4efc-aca9-42d897d6a3b8 | 2026-04-22 | Warnings | M013 |
| Aspirin | ASPIRIN | CVS PHARMACY | 904a2b21-d911-40c3-9e4b-59543ea5be4f | 2026-04-22 | Warnings | M013 |
| Pamprin Multi-Symptom Maximum Strength | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | Focus Consumer Healthcare, LLC | 60b3286d-5698-df50-e053-2991aa0afbe2 | 2026-04-20 | Warnings | M013 |
| Acetaminophen Extra Strength | ACETAMINOPHEN | CVS PHARMACY | af6fe4a9-2d18-4fed-b952-0a7866f65251 | 2026-04-20 | Warnings | M013 |
| Aspirin 81 mg | ASPIRIN | Preferred Pharmaceuticals Inc. | ac7f11d2-cbfd-4610-a652-fc2f1ea41d7e | 2026-04-20 | Warnings | M013 |
| Parry-500mg Acetaminophen | ACETAMINOPHEN | MDC PHARMACEUTICALS LIMITED | fb07ba10-3210-41bc-9310-c952118fdcf3 | 2026-04-17 | Warnings | M013 |
| Aspirin NSAID | ASPIRIN | Valu Merchandisers Company | 0cc46a81-54c9-44b7-b384-79d25255eff2 | 2026-04-17 | Warnings | M013 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Valu Merchandisers Company | 99de2c41-59b0-42e7-847e-e51229c6164f | 2026-04-17 | Warnings | M013 |
| Pain and Fever Childrens | ACETAMINOPHEN | Walgreen Company | 1f3e2895-5ef7-4e6a-8d2e-b805d148f980 | 2026-04-16 | Warnings | M013 |
| Childrens TYLENOL | ACETAMINOPHEN | Kenvue Brands LLC | b297aff8-a08b-4d37-b168-800a56564cbd | 2026-04-16 | Warnings | M013 |
| Childrens Tylenol | ACETAMINOPHEN | Kenvue Brands LLC | 9782fe86-d72a-4231-b1ba-d3f3b4ee49e3 | 2026-04-16 | Warnings | M013 |
| Pain Relief PM Extra Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | DOLGENCORP, LLC | 8e65478b-7a7b-416c-b8e3-23dad79f8cc1 | 2026-04-16 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | Valu Merchandisers Company | c9e384e5-fa9b-4c75-b5e3-16eb8db662ef | 2026-04-16 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Preferred Pharmaceuticals Inc. | b6abfbbb-9826-4cd6-940f-3a314480a5a5 | 2026-04-15 | Warnings | M013 |
| Good Sense Pain and Fever | ACETAMINOPHEN | L. Perrigo Company | f7137fe6-582e-43a4-8302-90ca54cd1de3 | 2026-04-14 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Cardinal Health 107, LLC | e13656eb-513e-411e-bdae-35ff1ba7cfc1 | 2026-04-13 | Warnings | M013 |
| CareOne Acetaminophen | ACETAMINOPHEN | American Sales Company | b4f54465-3232-4685-9570-90be00876577 | 2026-04-12 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198440 | acetaminophen 500 MG Oral Tablet | PSN | 103d109d-f520-409c-8da2-eb6b0fbec891 | 15 |
| 209459 | Tylenol Extra Strength 500 MG Oral Tablet | PSN | 103d109d-f520-409c-8da2-eb6b0fbec891 | 15 |
| 209459 | acetaminophen 500 MG Oral Tablet [Tylenol] | SBD | 103d109d-f520-409c-8da2-eb6b0fbec891 | 15 |
| 198440 | acetaminophen 500 MG Oral Tablet | SCD | 103d109d-f520-409c-8da2-eb6b0fbec891 | 15 |
| 198440 | APAP 500 MG Oral Tablet | SY | 103d109d-f520-409c-8da2-eb6b0fbec891 | 15 |
| 209459 | APAP 500 MG Oral Tablet [Tylenol] | SY | 103d109d-f520-409c-8da2-eb6b0fbec891 | 15 |
| 209459 | Tylenol 500 MG Oral Tablet | SY | 103d109d-f520-409c-8da2-eb6b0fbec891 | 15 |
| 209459 | Tylenol Extra Strength 500 MG Oral Tablet | SY | 103d109d-f520-409c-8da2-eb6b0fbec891 | 15 |
| 198440 | acetaminophen 500 MG Oral Tablet | PSN | bcb7eb24-16cb-439e-879f-48d2f5e8ba83 | 9 |
| 209459 | Tylenol Extra Strength 500 MG Oral Tablet | PSN | bcb7eb24-16cb-439e-879f-48d2f5e8ba83 | 9 |
| 209459 | acetaminophen 500 MG Oral Tablet [Tylenol] | SBD | bcb7eb24-16cb-439e-879f-48d2f5e8ba83 | 9 |
| 198440 | acetaminophen 500 MG Oral Tablet | SCD | bcb7eb24-16cb-439e-879f-48d2f5e8ba83 | 9 |
| 198440 | APAP 500 MG Oral Tablet | SY | bcb7eb24-16cb-439e-879f-48d2f5e8ba83 | 9 |
| 209459 | APAP 500 MG Oral Tablet [Tylenol] | SY | bcb7eb24-16cb-439e-879f-48d2f5e8ba83 | 9 |
| 209459 | Tylenol 500 MG Oral Tablet | SY | bcb7eb24-16cb-439e-879f-48d2f5e8ba83 | 9 |
| 209459 | Tylenol Extra Strength 500 MG Oral Tablet | SY | bcb7eb24-16cb-439e-879f-48d2f5e8ba83 | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50580-937-01 | 50580093701 | 12 VIAL in 1 PACKAGE (50580-937-01) / 10 TABLET, FILM COATED in 1 VIAL | 12 vial | 2019-08-19 | 0000-00-00 | No | No | Current |
| 50580-937-02 | 50580093702 | 12 VIAL in 1 PACKAGE (50580-937-02) / 10 TABLET, FILM COATED in 1 VIAL | 12 vial | 2019-09-16 | 0000-00-00 | No | No | Current |
| 50580-937-03 | 50580093703 | 2 TABLET, FILM COATED in 1 POUCH (50580-937-03) | 2020-07-31 | 0000-00-00 | No | No | Current | |
| 50580-937-04 | 50580093704 | 3 POUCH in 1 CARTON (50580-937-04) > 2 TABLET, FILM COATED in 1 POUCH | 3 pouch | 2020-07-31 | 0000-00-00 | No | No | Current |
| 50580-937-05 | 50580093705 | 50 POUCH in 1 CARTON (50580-937-05) > 2 TABLET, FILM COATED in 1 POUCH | 50 pouch | 2020-07-31 | 0000-00-00 | No | No | Current |
| 50580-937-06 | 50580093706 | 1 BOTTLE in 1 CARTON (50580-937-06) / 24 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 2020-08-31 | 0000-00-00 | No | No | Current |
| 50580-937-07 | 50580093707 | 1 BOTTLE in 1 CARTON (50580-937-07) / 100 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 2020-08-31 | 0000-00-00 | No | No | Current |
| 50580-937-10 | 50580093710 | 1 BOTTLE in 1 CARTON (50580-937-10) / 50 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 2020-08-31 | 0000-00-00 | No | No | Current |
| 50580-937-15 | 50580093715 | 1 BOTTLE in 1 CARTON (50580-937-15) / 225 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 2020-08-31 | 0000-00-00 | No | No | Current |
| 50580-937-19 | 50580093719 | 325 TABLET, FILM COATED in 1 BOTTLE (50580-937-19) | 2020-08-31 | 0000-00-00 | No | No | Current | |
| 50580-937-20 | 50580093720 | 50 POUCH in 1 CARTON (50580-937-20) > 2 TABLET, FILM COATED in 1 POUCH | 50 pouch | 2020-07-31 | 0000-00-00 | No | No | Current |
| 50580-937-23 | 50580093723 | 3 POUCH in 1 CARTON (50580-937-23) / 2 TABLET, FILM COATED in 1 POUCH | 3 pouch | 2026-01-15 | No | No | Current | |
| 50580-937-25 | 50580093725 | 2500 POUCH in 1 CASE (50580-937-25) / 2 TABLET, FILM COATED in 1 POUCH | 2500 pouch | 2025-12-28 | No | No | Current | |
| 50580-937-37 | 50580093737 | 320 TABLET, FILM COATED in 1 BOTTLE (50580-937-37) | 2026-03-31 | No | No | Current | ||
| 50580-937-50 | 50580093750 | 50 POUCH in 1 CARTON (50580-937-50) / 2 TABLET, FILM COATED in 1 POUCH | 50 pouch | 2025-12-28 | No | No | Current | |
| 50580-937-51 | 50580093751 | 50 POUCH in 1 CARTON (50580-937-51) / 2 TABLET, FILM COATED in 1 POUCH | 50 pouch | 2025-12-28 | No | No | Current | |
| 50580-937-66 | 50580093766 | 2 BOTTLE in 1 CARTON (50580-937-66) / 100 TABLET, FILM COATED in 1 BOTTLE | 2 bottle | 2024-05-01 | No | No | Current |